Watz, Henrik

An official European Respiratory Society statement on physical activity in COPD

Watz, H., Pitta, F., Rochester, C. L., Garcia-Aymerich, J., ZuWallack, R., Troosters, T., Vaes, A. W., Puhan, M. A., Jehn, M., Polkey, M. I., et al. (2014) · European Respiratory Journal

Chronic Obstructive Pulmonary Disease (COPD) ResearchPhysical Activity and Health

Cited by 526

Decreasing Cardiac Chamber Sizes and Associated Heart Dysfunction in COPD

Watz, H., Waschki, B., Meyer, T., Kretschmar, G., Kirsten, A., Claussen, M., & Magnussen, H. (2010) · Chest

Chronic Obstructive Pulmonary Disease (COPD) ResearchCardiovascular Function and Risk Factors

Cited by 277

SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects

Holz, O., Khalilieh, S., Ludwig-Sengpiel, A., Watz, H., Stryszak, P., Soni, P., Tsai, M., Sadeh, J., & Magnussen, H. (2010) · European Respiratory Journal

Chronic Obstructive Pulmonary Disease (COPD) ResearchChemokine receptors and signaling

Cited by 183

COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type‐2 and PDE4 gene expression in sputum

Singh, D., Bassi, M., Balzano, D., Lucci, G., Emirova, A., Anna Nandeuil, M., Jellema, G., Afolabi, E. K., Leaker, B., Kornmann, O., et al. (2021) · Journal of Cellular and Molecular Medicine

Chronic Obstructive Pulmonary Disease (COPD) ResearchAsthma and respiratory diseases

Cited by 20